New York 2025-2026 Regular Session

New York Assembly Bill A04759

Introduced
2/6/25  
Refer
2/6/25  
Report Pass
5/27/25  
Refer
5/27/25  
Report Pass
6/5/25  
Refer
6/5/25  

Caption

Relates to the medical use of cannabis; repeals controlled substances therapeutic research act.

Summary

This bill revises New York’s medical cannabis framework to replace the paper registry-card model with an electronic certification and validation system. It changes how practitioners certify patients, how registered organizations verify eligibility, and how designated caregivers are registered and used. The bill also extends certification duration from one year to two years, allows practitioners to reissue or extend certifications, permits the board to establish QR codes or similar codes for use at dispensaries, and updates rules for caregiver designation, including lowering the minimum caregiver age to 18 in most cases. The bill also expands access and portability by creating medical cannabis reciprocity for out-of-state patients from other U.S. jurisdictions and allowing New York certified patients to obtain medical cannabis in other states where permitted. It updates possession limits to tie them to Penal Law section 222.05 or a sixty-day supply, clarifies home cultivation rules for certified patients and caregivers age 18 or older, and adds restrictions on selling homegrown cannabis while allowing limited transfers to other certified patients. In addition, it strengthens confidentiality rules, makes practitioner information publicly searchable unless opted out, and imposes misdemeanor liability for fraudulent manipulation of patient or caregiver information by practitioners or registered-organization personnel. The bill would substantially amend multiple sections of the Cannabis Law, especially sections governing definitions, practitioner certifications, patient possession, dispensary validation, caregiver registration, home cultivation, and public disclosure. It also repeals Article 33-A of the Public Health Law, which concerns the Controlled Substances Therapeutic Research Act, and directs state agencies to transfer related records to the Office of Cannabis Management and the state archives. The measure would shift administrative responsibility away from the old registry-card structure and toward a more streamlined, digitally validated medical cannabis system. Overall sentiment in committee appears strongly favorable. The bill advanced unanimously in the Assembly Health Committee and then moved forward through Codes and Rules with broad support, though not without some opposition in the later committees. The vote pattern suggests general agreement with modernizing the medical cannabis program and improving access, while still reflecting some concern about the scope of the changes and the legal/administrative implications of replacing the existing system. The main points of contention are likely the move away from registry identification cards, the expansion of caregiver eligibility and reciprocity, and the reduced age threshold for caregivers and patient cultivation. Other potentially debated issues include privacy and data-sharing changes, the public posting of practitioner information, and the new criminal penalty for fraudulent handling of certification data. Supporters appear to favor simplification, access, and modernization, while any critics would likely focus on oversight, security, and implementation burdens.

Impact

The bill would amend the Cannabis Law to replace registry-card procedures with electronic certifications and organization-based validation, revise possession and cultivation rules, expand caregiver and patient access, and add reciprocity for out-of-state medical cannabis patients. It would also repeal Article 33-A of the Public Health Law and require transfer of related records, thereby removing the Controlled Substances Therapeutic Research Act from the Public Health Law and consolidating medical cannabis administration under the Office of Cannabis Management and related cannabis-law provisions.

Sentiment

Committee action indicates broad support for the bill, with unanimous approval in the Health Committee and favorable advancement through Codes and Rules despite some dissenting votes in the latter committees. The overall tone suggests the Legislature viewed the measure as a modernization and access-expansion bill, though the presence of no votes in later stages shows that some members had reservations about the policy and administrative changes.

Contention

Likely areas of disagreement include the elimination of physical registry cards, the shift to electronic validation and QR codes, and the broader reciprocity provisions for out-of-state patients. The bill’s lowering of the caregiver age threshold to 18, changes to home cultivation, and the public disclosure of practitioner information may also draw concern. In addition, the new misdemeanor penalty for fraudulent manipulation of patient or caregiver information could be viewed as either a necessary safeguard or an expansion of liability, depending on perspective.

Companion Bills

NY S03294

Same As Relates to the medical use of cannabis; repeals controlled substances therapeutic research act.

Previously Filed As

NY S03294

Relates to the medical use of cannabis; repeals controlled substances therapeutic research act.

NY S02566

Relates to the medical use of cannabis; provides medical cannabis patient reciprocity; repeals the controlled substances therapeutic research act.

NY AB1103

Controlled substances: research.

NY AB2489

Controlled substances: research.

NY H984

Regulate Research of Medical Cannabis

NY HB190

Relative to therapeutic cannabis possession limits.

NY SF209

Illegal cannabis and controlled substances tax repeal

NY HB2752

Setting standards for patient and caregiver identification cards to ensure legal access to medical cannabis, establishing the Kansas medical cannabis agency within the department of health and environment and removing cannabis from the Kansas uniform controlled substances act.

NY HF2426

Plant canopy that a medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.

NY SB734

Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing a fee.

Similar Bills

No similar bills found.